Eledon Pharmaceuticals (ELDN) Shareholder's Equity Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.98% |
| Dec 31, 2025 | 29.85% |
| Sep 30, 2025 | 73.64% |
| Jun 30, 2025 | 178.41% |
| Mar 31, 2025 | 183.62% |
| Dec 31, 2024 | 228.79% |
| Sep 30, 2024 | -42.79% |
| Jun 30, 2024 | -246.67% |
| Mar 31, 2024 | -194.16% |
| Dec 31, 2023 | -303.83% |
| Sep 30, 2023 | -74.77% |
| Jun 30, 2023 | -70.70% |
| Mar 31, 2023 | -52.15% |
| Dec 31, 2022 | -85.49% |
| Sep 30, 2022 | -17.37% |
| Jun 30, 2022 | -16.32% |
| Mar 31, 2022 | -14.98% |
| Dec 31, 2021 | -13.96% |
| Sep 30, 2021 | 693.96% |
| Jun 30, 2021 | 1,808.09% |
| Mar 31, 2021 | 1,465.53% |
| Dec 31, 2020 | 1,913.69% |
| Sep 30, 2020 | 60.90% |
| Jun 30, 2020 | -41.64% |
| Mar 31, 2020 | 18.29% |
| Dec 31, 2019 | -34.69% |
| Sep 30, 2019 | -27.06% |
| Jun 30, 2019 | -25.48% |
| Mar 31, 2019 | -59.14% |
| Dec 31, 2018 | -25.50% |
| Sep 30, 2018 | -11.13% |
| Jun 30, 2018 | -8.22% |
| Mar 31, 2018 | 4.00% |
| Dec 31, 2017 | 819.91% |
| Sep 30, 2017 | -31.85% |
| Jun 30, 2017 | -39.72% |
| Mar 31, 2017 | -54.55% |
| Dec 31, 2016 | -197.12% |
| Sep 30, 2016 | -57.92% |
| Jun 30, 2016 | -53.01% |
| Mar 31, 2016 | -43.44% |
| Dec 31, 2015 | -97.31% |
| Sep 30, 2015 | -29.24% |
| Dec 31, 2014 | 287.27% |